Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients.

Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients.

Steroid-resistant GvHD is one of the most significant causes of mortality following allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Treatment with mesenchymal stromal cells (MSC) seems to be a promising solution, however the results from clinical studies are still equivocal. Better select...

Full description

Bibliographic Details
Main Authors: Liad Hinden, Mordechai Avner, Polina Stepensky, Reuven Or, Osnat Almogi-Hazan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0217572

Similar Items

Similar Items